| Literature DB >> 24666273 |
Wladimir Wertelecki1, Lyubov Yevtushok, Natalia Zymak-Zakutnia, Bin Wang, Zoriana Sosyniuk, Serhiy Lapchenko, Holly H Hobart.
Abstract
This population-based descriptive epidemiology study demonstrates that rates of conjoined twins, teratomas, neural tube defects, microcephaly, and microphthalmia in the Rivne province of Ukraine are among the highest in Europe. The province is 200 km distant from the Chornobyl site and its northern half, a region known as Polissia, is significantly polluted by ionizing radiation. The rates of neural tube defects, microcephaly and microphthalmia in Polissia are statistically significantly higher than in the rest of the province. A survey of at-birth head size showed that values were statistically smaller in males and females born in one Polissia county than among neonates born in the capital city. These observations provide clues for confirmatory and cause-effect prospective investigations. The strength of this study stems from a reliance on international standards prevalent in Europe and a decade-long population-based surveillance of congenital malformations in two distinct large populations. The limitations of this study, as those of other descriptive epidemiology investigations, is that identified cause-effect associations require further assessment by specific prospective investigations designed to address specific teratogenic factors.Entities:
Keywords: Chornobyl; blastopathies; congenital malformations; ionizing radiation; sex ratio
Mesh:
Year: 2014 PMID: 24666273 PMCID: PMC4233949 DOI: 10.1111/cga.12051
Source DB: PubMed Journal: Congenit Anom (Kyoto) ISSN: 0914-3505 Impact factor: 1.409
Figure 1Schematic representation of Rivne province counties indicating those with soils characteristics of a region called Polissia and those counties designated as impacted by Chornobyl ionizing radiation. Also shown is the area of “distant” Polissia, the location sites of nuclear power plants and the trajectory of major rivers of the region.
Population-based rates of unduplicated individuals and male-female (MF) proportions and ratios (M:F) of selected congenital malformations among live births in Rivne, Ukraine (2000–2009)1
Population-based unduplicated rates per 10 000 live births of individuals with selected congenital malformations in Rivne, Ukraine1
| Categories | Polissia | Non-Polissia | Polissia | Non-Polissia | Polissia vs. non-Polissia | ||||
|---|---|---|---|---|---|---|---|---|---|
| 2000–2004 | 2005–2009 | 2000–2004 | 2005–2009 | 2000–2009 | 2000–2009 | OR | CL | ||
| Neural tube defects (NTD) | 29.1 | 23.5 | 18.4 | 14.8 | 26.1 | 16.4 | 1.59 | 1.26, 2.02 | |
| Cephalad | 9.5 | 10.1 | 7.8 | 4.8 | 9.8 | 6.2 | 1.59 | 1.08, 2.37 | |
| Anencephaly | 6.2 | 4.1 | 5.1 | 3.0 | 5.1 | 4.0 | – | n/s | – |
| Isolated | 5.6 | 3.9 | 4.8 | 3.0 | 4.7 | 3.8 | – | n/s | – |
| Non-NTD malformations | n/c | n/c | n/c | – | n/c | n/c | – | n/c | – |
| Cranio-inien-rachis-schisis | 3.3 | 5.9 | 2.7 | 1.8 | 4.7 | 2.2 | 2.15 | 1.15, 4.16 | |
| Isolated | 2.1 | 4.1 | 1.8 | 1.5 | 3.2 | 1.6 | 1.94 | 0.92, 4.27 | |
| Other malformations | n/c | 1.8 | n/c | n/c | 1.5 | n/c | – | n/s | – |
| Spina bifida cervico-thoracic | 3.3 | 1.6 | – | n/c | 2.3 | n/c | 4.29 | 1.40, 17.5 | |
| Isolated | 2.4 | 1.6 | – | n/c | 1.9 | n/c | 3.53 | 1.11, 14.7 | |
| Other malformations | n/c | – | – | – | n/c | – | – | n/c | – |
| Spina bifida lumbo-sacral | 10.1 | 10.3 | 7.2 | 7.0 | 10.2 | 7.1 | 1.44 | 0.99, 2.09 | |
| Isolated | 8.9 | 9.3 | 6.0 | 6.5 | 9.1 | 6.3 | 1.45 | 0.98, 2.16 | |
| Syndromes | n/c | – | – | – | n/c | – | – | n/c | – |
| Other malformations | n/c | n/c | n/c | n/c | 0.97 | 0.8 | – | n/s | – |
| Spina bifida site unknown | 3.3 | – | n/c | – | 1.5 | n/c | – | n/s | – |
| Isolated | 3.3 | – | n/c | – | 1.5 | n/c | – | n/s | – |
| Spina bifida combined | 16.6 | 11.9 | 8.4 | 8.0 | 14.1 | 8.2 | 1.71 | 1.24, 2.40 | |
| Encephalocele | 3.0 | 1.6 | 2.1 | 2.0 | 2.2 | 2.1 | – | n/s | – |
| Isolated | 2.1 | 1.3 | 1.5 | 1.5 | 1.7 | 1.5 | – | n/s | – |
| Syndromes | n/c | n/c | – | – | n/c | n/c | – | n/c | – |
| Other malformations | n/c | – | n/c | n/c | n/c | n/c | – | n/c | – |
| Microcephaly | 5.3 | 6.7 | 3.3 | 3.3 | 6.1 | 3.3 | 1.85 | 1.10, 3.18 | |
| Isolated | 2.7 | 1.3 | n/c | 1.3 | 1.9 | 1.1 | – | n/s | – |
| Syndromes | n/c | 2.8 | 2.1 | 1.8 | 2.1 | 1.9 | – | n/s | – |
| Other malformations | 1.5 | 2.6 | n/c | n/c | 2.1 | n/c | 7.57 | 1.76, 68.2 | |
| Microphthalmos | 1.8 | 3.1 | n/c | n/c | 2.5 | 0.8 | 3.03 | 1.15, 9.32 | |
| Isolated | n/c | 1.6 | – | n/c | 1.1 | n/c | – | n/s | – |
| Syndromes | – | n/c | n/c | – | n/c | n/c | – | n/c | – |
| Other malformations | n/c | n/c | n/c | – | 1.0 | n/c | 7.07 | 0.91, 318 | |
| Omphalocele | 1.8 | 1.8 | 2.4 | 4.3 | 1.8 | 3.4 | 0.52 | ( | 0.25, 1.07 |
| Isolated | n/c | n/c | 1.8 | 2.8 | 0.7 | 2.3 | 0.30 | ( | 0.09, 0.84 |
| Syndromes | n/c | n/c | n/c | – | n/c | n/c | – | n/c | – |
| Other malformations | n/c | n/c | n/c | 1.5 | 0.8 | 1.0 | – | n/s | – |
| Gastroschisis | n/c | 3.4 | 3.3 | 3.0 | 2.3 | 3.1 | – | n/s | – |
| Isolated | n/c | 3.4 | 3.0 | 3.0 | 2.2 | 3.0 | – | n/s | – |
| Other malformations | n/c | – | n/c | – | n/c | n/c | – | n/c | – |
| Urinary bladder exstrophy | n/c | n/c | n/c | n/c | 1.1 | 0.7 | – | n/s | – |
| Isolated | n/c | n/c | n/c | n/c | 1.1 | n/c | – | n/s | – |
| Other malformations | – | – | n/c | – | – | n/c | – | n/c | – |
| Conjoined twins | n/c | – | n/c | n/c | n/c | 0.7 | – | n/s | – |
| Isolated | n/c | – | n/c | n/c | n/c | n/c | – | n/c | – |
| Other malformations | – | – | n/c | n/c | – | n/c | – | n/c | – |
| Teratomas | 1.5 | n/c | n/c | n/c | 0.8 | n/c | – | n/s | – |
| Isolated | 1.5 | n/c | n/c | n/c | 0.8 | n/c | – | n/s | – |
| Sacro-coccygeal | 1.5 | n/c | n/c | n/c | 0.8 | n/c | – | n/s | – |
| Isolated | 1.5 | n/c | n/c | n/c | 0.8 | n/c | – | n/s | – |
| All | 42.4 | 39.8 | 29.8 | 28.4 | 41.0 | 29.0 | 1.42 | 1.18, 1.70 | |
| Isolated | 32.6 | 28.2 | 22.3 | 23.3 | 30.3 | 22.9 | 1.33 | 1.08, 1.63 | |
| Syndromes | 2.4 | 4.1 | 2.7 | 1.8 | 3.3 | 2.2 | – | n/s | – |
| Other malformations | 7.4 | 7.5 | 4.8 | 3.3 | 7.5 | 4.0 | 1.88 | 1.18, 3.06 | |
Actual counts of unduplicated individuals are found in Table S1b. All births in Rivne are 145 437, in Polissia, 72 379, and in non-Polissia, 73 058 (observations in non-Polissia are in italics). Individuals with congenital malformations (CM) are represented only in one category and include those liveborn or not and singletons or not; individuals with holoprosencephaly are excluded from the Tables 2, and S1a,b,c series; population rates of CM detected up to one year of age are calculated per 10 000 live births. One-tailed P-values are calculated with 95% confidence limits for categories with at least five individuals represented or alternatively are shown as not computed (n/c). P-values are denoted by
***, ≤0.001; **, ≤0.01; *, ≤0.05, or n/s for non-significant. P-values in parentheses indicate a negative association. Odds ratio (OR) and confidence limits (CL) are also shown.
Cephalad includes iniencephaly, anencephaly (or acrania) associated or not with rachis-schisis or spina bifida. Encephaloceles are computed separately.
Microphthalmia (c-1); cleft lip (c-2); omphalocele (c-3); esophageal atresia (d-1).
Includes iniencephaly and anencephaly-rachis-schisis.
Excluded are two singletons and one twin with holoprosencephaly (hol-6, 20; tw-1); also excluded is an individual incompletely described (z-2) diagnosed at 20 weeks of gestation with a holoprosencephaly spectrum and a single orbit, who is represented among conjoined twins.Included in this category as isolated microcephaly are two individuals who had microcephaly and microphthalmia not associated with extra-ocular anomalies (ri-8, 12).
Excluded is one individual represented among anencephalics (c-1); four individuals with microcephaly (ri-8, 12; t-8; s-2); and one individual (z-2), who is represented among conjoined twins and further described in footnote (5).
Excluded is one individual represented among anencephalics (c-3); seven individuals with cranio-rachis-schises (f-2, 4–8; g-4); six individuals with spina bifida (h-1, 3; l-5, m-2, 5, 6); two individuals with microcephaly (t-9, u-2); and two individuals with microphthalmia (v-1; w-1).
Excluded is one individual with spina bifida (h-3).
Excluded is one member of a set of conjoined twins (h-1) with spina bifida and represented among other individuals with spina bifida.
All individuals with microcephaly and associated anomalies in Rivne Province, Ukraine (2000–2009)a
| Category | Polissia | Non-Polissia | Rivne Province | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| All | Rate | Sex | All | Rate | Sex | All | Rate | M : F | |||
| M | F | M | F | ||||||||
| MIC (all individuals) | 46 | 6.4 | 22 | 24 | 25 | 3.4 | 13 | 12 | 71 | 4.9 | 0.97 |
| MIC (no HOLOP, no mOPH) | 26 | 3.6 | 10 | 16 | 10 | 1.4 | 4 | 6 | 36 | 2.5 | 0.64 |
| Isolated | 12 | 1.7 | 3 | 9 | 8 | 1.1 | 3 | 5 | 20 | 1.4 | 0.43 |
| MIC and HOLOP (no mOPH) | 1 | n/c | 1 | 1 | n/c | 1 | 2 | n/c | n/c | ||
| Isolated | 1 | n/c | 1 | 1 | n/c | n/c | |||||
| MIC and mOPH (no HOLOP) | 3 | n/c | 3 | 3 | n/c | n/c | |||||
| Isolated | 2 | n/c | 2 | 2 | n/c | n/c | |||||
| MIC and mOPH and HOLOP | 1 | n/c | 1 | 1 | n/c | n/c | |||||
| Syndromic MIC | 15 | 2.1 | 10 | 5 | 14 | 1.9 | 8 | 6 | 29 | 2.0 | 1.64 |
| Patau Syndrome | 1 | n/c | 1 | 1 | n/c | n/c | |||||
| FASD | 9 | 1.2 | 7 | 2 | 11 | 1.5 | 6 | 5 | 20 | 1.4 | 1.86 |
| mOPH (no MIC) (all individuals) | 22 | 3.0 | 10 | 12 | 8 | 1.1 | 4 | 4 | 30 | 2.1 | 0.88 |
| mOPH (no HOLOP) | 16 | 2.2 | 7 | 9 | 5 | 0.7 | 2 | 3 | 21 | 1.4 | 0.75 |
| Isolated | 8 | 1.1 | 5 | 3 | 4 | n/c | 1 | 3 | 12 | 0.8 | 1.00 |
| mOPH and HOLOP | 2 | n/c | 1 | 1 | 2 | n/c | n/c | ||||
| Isolated | 1 | n/c | 1 | 1 | n/c | n/c | |||||
| Syndromic mOPH | 6 | 0.8 | 3 | 3 | 1 | n/c | 1 | 7 | 0.5 | n/c | |
| mOPH and Patau Syndrome | 5 | 0.7 | 3 | 2 | 1 | n/c | 1 | 6 | 0.4 | n/c | |
Statistically significantly higher t-rates in Polissia are noted among all MIC individuals (P-value 0.008; OR 1.86; CL 1.12, 3.16); among MIC excluding HOLOP and mOPH (P-value 0.005; OR 2.63; CL 1.23, 6.10); among mOPH excluding MIC (P-value 0.008; OR 2.78; CL 1.19, 7.21); among mOPH excluding HOLOP (P-value 0.01; OR 3.23; CL 1.13, 11.3); and nearly significantly higher rates among syndromic mOPH (P-value 0.06; OR 6.06; CL 0.73, 278.6).
Individuals may be represented in various categories. Unduplicated individuals are presented in Table 2 and further information is given in the Data Supplement.
Includes 4 individuals with mOPH.
Excludes associated syndromic malformations.
Includes one individual (s-2) with concurrent MIC-FASD-mOPH.
Includes two individuals with mOPH-Patau-HOLOP combination (hol-22, 23).
F, female; FASD, fetal alcohol spectrum disorder; HOLOP, holoprosencephaly; M, male; M : F, male : female ratio; MIC, microcephaly; mOPH, microphthalmia; n/c, not computed.
Highest population ratesa in Europe (2005–2009)b of four congenital malformations (including percent of NTD-impacted terminated pregnancies)c compared to rates in Polissia and non-Polissia regions of Rivne Province, Ukraine (2000–2009)
| Neural tube defects | Microcephaly | Microphthalmia | Conjoined twins |
|---|---|---|---|
| 25.96 (51) | 6.35 Polissia | 3.57 Polissia | 0.55 Rivne |
| 16.33 (68) non-Polissia | 5.35 Wales | 1.63 Wales | 0.49 North England |
| 14.47 (81) N. England | 5.03 South-West England | 1.51 Dublin | 0.35 Wales and Wessex |
| 13.60 (84) Wales | 4.52 Valencia | 1.22 N Netherlands and non-Polissia | 0.31 E. Midlands and South Yorkshire |
| 12.77 (87) Paris | 3.88 Basque C. (Spain) | 1.21 South-West England | 0.26 Wiekopolska |
Rate per 10 000 births of congenital malformations (not individuals) inclusive of live births, fetal deaths of 20 or more weeks of gestation and termination of pregnancies.
Rates reported by full member registries located in Europe who reported at least 30 000 births during the 2006–2008 and at least 30 instances of neural tube defects (NTD). These criteria were met by the 19 registries shown. Excluded were registries from Zagreb (Croatia), Odense (Denmark), Strasbourg (France), Mainz (Germany), Cork and Kerry (Ireland), SE Ireland, Malta, Barcelona (Spain), Vaud (Switzerland); South Portugal. Excluded are registries from Saxony-Anhalt (Germany) and Styria (Austria) whose data are under review. Ukraine is excluded and instead, rates from Rivne province in Ukraine subdivided as Polissia and non-Polissia regions are presented. The rates are calculated adhering to EUROCAT methods. Eurocat data are accessible on the web-site. Note: EUROCAT occasionally introduces data updates. The data shown above was accessed on 29 November 2013.
Percent of pregnancy terminations.
Figure 3Twin individuals with neural tube defects (NTD) and twinning events among their relatives (2000–2009).
Individualsa with prevalent malformation syndromes associated with microcephaly in Rivne Province (2000–2009)
| Category | Polissia | Non-Polissia | Rivne Province | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rate | All | Sex | Rate | All | Sex | Rate | All | Sex | ||||
| M | F | M | F | M | F | |||||||
| FASD | 5.1 | 37 | 19 | 18 | 5.7 | 42 | 25 | 17 | 5.4 | 79 | 44 | 35 |
| Included in alternative categories | 1.4 | 10 | 7 | 3 | 1.5 | 11 | 6 | 5 | 1.4 | 21 | 13 | 8 |
| among Microcephaly | 1.2 | 9 | 7 | 2 | 1.5 | 11 | 6 | 5 | 1.4 | 20 | 13 | 7 |
| PATAU SYNDROME/TRISOMY 13 | n/c | 9 | 5 | 4 | n/c | 11 | 8 | 2 | n/c | 20 | 13 | 6 |
| Included in alternative categories | n/c | 8 | 5 | 3 | n/c | 9 | 6 | 2 | n/c | 17 | 11 | 5 |
| Holoprosencephaly | n/c | 5 | 3 | 2 | n/c | 6 | 4 | 1 | n/c | 11 | 7 | 3 |
| Microphthalmia | n/c | 2 | 1 | 1 | n/c | 1 | 1 | n/c | 3 | 2 | 1 | |
| Omphalocele | n/c | 1 | 1 | n/c | 1 | 1 | n/c | 2 | 1 | 1 | ||
| Microcephaly | n/c | 1 | 1 | n/c | 1 | 1 | ||||||
| HOLOPROSENCEPHALY | n/c | 13 | 8 | 5 | n/c | 23 | 12 | 7 | n/c | 36 | 20 | 12 |
| Associations | ||||||||||||
| and Microcephaly | n/c | 2 | 2 | n/c | 1 | 1 | n/c | 3 | 3 | |||
| and Microphthalmia | n/c | 3 | 2 | 1 | n/c | 2 | 1 | 1 | n/c | 5 | 3 | 2 |
| and Teratoma | n/c | 1 | 1 | n/c | 1 | 1 | ||||||
In contrast to Table 2 and its derivatives where individuals are only represented once, in this table the rate is calculated as total impacted individuals who may be represented in several malformation categories (shown in capital letters). Individuals represented in sub-categories are mutually exclusive. Also note an alternative presentation of similar data in Table 5 and clinical summaries of all individuals contained in the Data Supplement. M indicates males and F indicates females.
FASD, Fetal Alcohol Spectrum Disorders.
Includes Patau syndrome (see above).
Includes one individual (hol-6) with holoprosencephaly-microcephaly-microphthalmos association.
Excludes above individual (hol-6).
Included one individual with cervico-faringeal teratoblastoma (neo-1).
n/c, not computed.
Alcohol consumption by pregnant women (%)
| Area of Residence | Women | AE | OR | CL | |
|---|---|---|---|---|---|
| Polissia | 852 | 13 (1.53) | – | – | – |
| Non-Polissia | 1417 | 67 (4.73) | 0.31 | <0.001 | 0.16, 0.58 |
| Rivne City | 566 | 36 (6.36) | 0.23 | <0.001 | 0.11, 0.45 |
| Khmelnytsky City | 1062 | 47 (4.43) | 0.33 | <0.001 | 0.17, 0.63 |
Data from Rivne (2009–2010) and Khmelnytsky (2010–2011).
“Alcohol Exposed” implies occasional consumption prior or during pregnancy of at least ≥5 standard drinks (sd), three times, or 3–4 sd, four times, or 1–2 sd, ≥10 times or alternatively almost daily consumption of small amounts or alternatively, a positive answer to at least two questions that follow: “in the past year”.
“Has a friend or family member ever told you about things you said or did while drinking that you could not remember?”.
“Have close friends or relatives worried or complained about your drinking?”.
“Have you had a drink first thing in the morning to steady your nerves or to get rid of a hangover?”.
“Have you felt you ought to cut down on your drinking?”.
“Have people annoyed you by criticizing your drinking?”.
“Have you felt bad or guilty about your drinking?” (adapted from Kfir M, Yevtushok L, Onishchenko S et al. in Ultrasound ObstetGynecol 2009;33:683–689; Bakhireva L, Wilsnack S, Kristjanson A et al. in J Stud Alcohol Drugs 2011;72(4):536–544).
Whole body counts of incorporated ionizing radiation in Rivne diagnostic center's ambulatory outpatients
| Distant Polissia | Non-Distant Polissia | Non- Polissia | |
|---|---|---|---|
| Pregnant Women | 1156 | 2534 | 2336 |
| Above Bq norm | 557 (48.2) | 155 (6.1) | 3 (0.1) |
| Children | 1338 | 3671 | 1697 |
| Above Bq norm (%) | 162 (12.1) | 50 (1.4) | 1 (0.1) |
| Adult Males | 2117 | 5885 | 4325 |
| Above Bq norm (%) | 136 (6.4) | 22 (0.4) | – |
Includes Zarichne, Dubrovytsia, and Rokytne counties.
Includes Volodymyrets, Sarny, Berezne, and Kostopil counties.
Includes remaining Rivne counties not mentioned in (a) or (b).
Pregnant women seeking prenatal ultrasound examinations at the Rivne Regional Diagnostic Center (2008–2011) who volunteered to undergo the procedure.
Official limits (norms) are 3700 and 14 800 Bq of 137Cs for subjects under 15 years of age and adults respectively.
2000–2011 data.
Radiometry of dried stems of potato plants from Rivne Polissia region
| Sample | Measurements | ||
|---|---|---|---|
| 90Sr, Bq/kg | 137Cs, Bq/kg | ||
| Initial | Repeat | ||
| A | 43.4 ± 17.2 | 46.8 ± 21.4 | 88.3 ± 36.4 |
| B | 49.9 ± 17.9 | 32.1 ± 24.1 | 63.6 ± 39.3 |
| C | 41.3 ± 19.9 | 46.4 ± 19.2 | 24.0 ± 22.0 |
| D | 82.3 ± 21.3 | 72.2 ± 20.0 | |
| E | 88.3 ± 23.1 | 84.4 ± 28.1 | 46.1 ± 34.6 |
| F | 95.6 ± 23.1 | 143.2 ± 29.6 | |
| G | 327.2 ± 86.6 | 87.3 ± 25.1 | 54.8 ± 31.4 |
Water, fuel and food sources consumed in Polissia a,b
| Water (%) | Well | Spring | Bottled | Piped |
|---|---|---|---|---|
| 85.4 | 9.4 | 50.0 | 5.3 | |
| Fuel (%) | Wood | Gas | Central | Peat |
| Heating | 76.7 | 17.5 | 9.0 | 1.8 |
| Cooking | 52.3 | 48.9 | – | – |
| Food (%) | Own | Local | Imported | |
| Pork | 91.3 | 9.9 | 0 | |
| Chicken | 77.3 | 16.2 | 2.0 | |
| Milk | 71.8 | 15.1 | 0 | |
| Vegetables | 98.0 | 6.4 | 1.2 | |
| Apples | 91.6 | 17.2 | 3.2 | |
| Estimated daily137Cs intake | Bq | |||
| Polissia | 268.25 | |||
| Upper permissible limit | 210.00 | |||
Extract from Dancause et al. (2010).
Mixed use, not additive percents.
Ministry of Health 1997 guidelines.
Figure 2Occipito-frontal circumferences (OFC in cm) of infants born after at least 38 weeks of gestation. Measurements were obtained from 2398 males and 2240 females from Zarichne county in the Polissia region compared to those of 12 542 males and 11 649 females from Rivne city located in the non-Polissia region of the Rivne province. The OFC values of males and females are smaller in Zarichne county. The contrast is statistically significant (P-value <0.0001 using permutation test and other) (Wang and Wertelecki 2013).
All individuals with omphaloceles or gastroschisis (2000–2009)
| Category | Polissia | Non-Polissia | Rivne Province | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rate | All | Sex | Rate | All | Sex | Rate | All | M : F | |||
| M | F | M | F | ||||||||
| OMPHALOCELE | 3.5 | 25 | 14 | 5 | 4.2 | 31 | 14 | 5 | 3.9 | 56 | 2.80 |
| Isolated | 0.7 | 5 | 4 | 2.3 | 17 | 7 | 3 | 1.5 | 22 | 3.67 | |
| Not isolated | 2.8 | 20 | 10 | 5 | 1.9 | 14 | 7 | 2 | 2.3 | 34 | 2.43 |
| Syndromic | n/c | 3 | 3 | n/c | 2 | 1 | 1 | 0.3 | 5 | n/c | |
| Non-Syndromic | 2.3 | 17 | 7 | 5 | 1.6 | 12 | 6 | 1 | 2.0 | 29 | 2.17 |
| Neural tube defects | 1.4 | 10 | 2 | 4 | n/c | 4 | 2 | 1.0 | 14 | n/c | |
| Microcephaly | n/c | 1 | 1 | n/c | 1 | 1 | n/c | 2 | n/c | ||
| Other Anomalies | 0.8 | 6 | 4 | 1 | 1.0 | 7 | 3 | 1 | 0.9 | 13 | 3.50 |
| GASTROSCHISIS | 2.3 | 17 | 5 | 12 | 3.1 | 23 | 11 | 7 | 2.8 | 40 | 0.84 |
| Isolated | 2.2 | 16 | 5 | 11 | 3.0 | 22 | 10 | 7 | 2.6 | 38 | 0.83 |
Individuals represented in sub-categories are mutually exclusive.
A statistically significantly higher rate (P-value 0.009; OR 0.30; CL 0.09, 0.84).
Includes four individuals (v-1; aa-2; w-1; bb-1) with Patau syndrome; includes two individuals (v-1; w-1) with omphalocele-Patau syndrome-microphthalmos.
F, females; M, males; M : F, male : female ratio; n/c, not computed.
Non-syndromic associations of congenital malformationsa, Rivne Province, Ukraine (2000–2009)
| Category | CTW | CEPH | SB | MIC | mOPH | CL/ | OM | GSTR | ESOPH | DIAPH | RENAL | BLEXTR | RECTAN | LIMB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P | 3 | 71 | 102 | 46 | 26 | 78 | 25 | 17 | 26 | 24 | 62 | 9 | 16 | 31 |
| nP | 5 | 45 | 60 | 25 | 9 | 79 | 31 | 23 | 17 | 26 | 63 | 5 | 29 | 49 |
| LB | 1 | 0 | 72 | 69 | 30 | 129 | 20 | 17 | 32 | 27 | 85 | 14 | 39 | 58 |
| S | 1 | 19 | 10 | 2 | 3 | 3 | 7 | 2 | 3 | 9 | 14 | 0 | 6 | 4 |
| ToP | 5 | 87 | 70 | 0 | 2 | 21 | 24 | 19 | 7 | 13 | 23 | 0 | 0 | 15 |
| SA | 1 | 10 | 10 | 0 | 0 | 4 | 5 | 2 | 1 | 1 | 3 | 0 | 0 | 3 |
| U | 2 | 34 | 22 | 0 | 0 | 2 | 18 | 5 | 3 | 6 | 11 | 0 | 3 | 9 |
| M | 1 | 32 | 73 | 35 | 16 | 100 | 28 | 16 | 22 | 26 | 69 | 8 | 22 | 37 |
| F | 5 | 50 | 67 | 36 | 19 | 55 | 10 | 19 | 18 | 18 | 45 | 6 | 20 | 34 |
| Twin | 0 | 5 | 3 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 2 | 0 | 1 | 4 |
| CTW | 8 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CEPH | 0 | 116 | ||||||||||||
| SB | 1 | 0 | 162 | |||||||||||
| MIC | 0 | 0 | 0 | 71 | ||||||||||
| mOPH | 0 | 1 | 0 | 5 | 35 | |||||||||
| CL/P | 0 | 2 | 2 | 4 | 4 | 157 | ||||||||
| OM | 1 | 8 | 6 | 2 | 2 | 6 | 56 | |||||||
| GSTR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40 | ||||||
| ESOPH | 0 | 4 | 0 | 2 | 2 | 3 | 0 | 0 | 43 | |||||
| DIAPH | 0 | 3 | 1 | 1 | 2 | 3 | 3 | 0 | 2 | 50 | ||||
| RENAL | 0 | 2 | 3 | 4 | 2 | 5 | 3 | 1 | 4 | 3 | 125 | |||
| BLEXTR | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 14 | ||
| RECTAN | 0 | 0 | 2 | 1 | 1 | 1 | 2 | 0 | 5 | 2 | 8 | 2 | 45 | |
| LIMB | 0 | 1 | 5 | 4 | 2 | 5 | 2 | 0 | 1 | 1 | 7 | 1 | 4 | 80 |
The regional and perinatal observations are presented above the diagonal of grey cells. In the grey cells are given the total numbers of individuals with the particular malformation (including those with holoprosencephaly). The numbers below the diagonal of grey cells reflect the associations with other malformations. Individuals with multiple malformations may be represented in multiple cells.
Associations with other unlisted congenital malformations are not included in the table.
Included are individuals with renal agenesis, hypoplasia, cystic kidneys and excluded are hydronephroses and ureteral obstructions.
ANOR, anorectal anomalies; BLEXTR, urinary bladder exstrophy; CEPH, cephalic neural tube defects; CL/P, cleft lip/palate; CTW, conjoined twins; DIAPH, diaphragmatic defects; ESOPH, esophageal anomalies; F, female; GSTR, gastroschisis; LB, live birth; LIMB, limb reduction defects; M, male; MIC, microcephaly; mOPH, microphthalmia; nP, non-Polissia region; OM, omphalocele; P, Polissia region; RENAL, renal anomalies; S, stillbirth; SA, spontaneous abortion; SB, spina bifida; ToP, termination of pregnancy; U, unknown sex.